Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2059)
All Articles published online
|
Jun 15, 2003 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhao P, Song X, Nin YY, Lu YL, Li XH. Loss of fragile histidine triad protein in human hepatocellular carcinoma. World J Gastroenterol 2003; 9(6): 1216-1219 [PMID: 12800227 DOI: 10.3748/wjg.v9.i6.1216] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v9/i6/1216.htm |
| Number | Citing Articles |
| 1 |
Yuping Xiao, Lili Mao, Chengbo Han, Jinyi Li, Lei Xu, Yan Xin. MSI/LOH and extron expression of the FHIT gene in gastric carcinoma. Frontiers of Medicine in China 2007; 1(1): 99 doi: 10.1007/s11684-007-0019-1
|
| 2 |
Po Zhao, Alfred King Yin Lam, Ya-Li Lu, Mei Zhong, Ling-Hong Chen, Xiao-Lu Pu. Aberrant FHIT protein expression in classical Hodgkin’s lymphoma: a potential marker. Pathology 2006; 38(5): 399 doi: 10.1080/00313020600922512
|
| 3 |
Rageshree Ramachandran, Sanjay Kakar. Fibrolamellar hepatocellular carcinoma. Diagnostic Histopathology 2010; 16(8): 388 doi: 10.1016/j.mpdhp.2010.06.005
|
| 4 |
Juliette Martin, Jean-François Dufour. Tumor suppressor and hepatocellular carcinoma. World Journal of Gastroenterology 2008; 14(11): 1720-1733 doi: 10.3748/wjg.14.1720
|
| 5 |
Prashant Bavi, Zeenath Jehan, Valerie Atizado, Hassan Al-Dossari, Fouad Al-Dayel, Asmah Tulbah, Samir S. Amr, Salwa S. Sheikh, Adnan Ezzat, Hassan El-Solh, Shahab Uddin, Khawla Al-Kuraya. Prevalence of Fragile Histidine Triad Expression in Tumors from Saudi Arabia: A Tissue Microarray Analysis. Cancer Epidemiology, Biomarkers & Prevention 2006; 15(9): 1708 doi: 10.1158/1055-9965.EPI-05-0972
|
| 6 |
Po Zhao, Yali Lu, Mei Zhong, Lin Liu, Bing Li. Inverse correlation of aberrant expression of fragile histidine triad (FHIT) protein with cyclin D1 protein and prognosis in Chinese patients with cholangiocarcinoma. Acta Oncologica 2008; 47(8): 1557 doi: 10.1080/02841860802216339
|
| 7 |
Rozenn Josse, Julie Dumont, Alain Fautrel, Marie-Anne Robin, André Guillouzo. Identification of early target genes of aflatoxin B1 in human hepatocytes, inter-individual variability and comparison with other genotoxic compounds. Toxicology and Applied Pharmacology 2012; 258(2): 176 doi: 10.1016/j.taap.2011.10.019
|
| 8 |
Fang Wang, Stacy Denison, Jin‐Ping Lai, Leslie A. Philips, Damien Montoya, Norman Kock, Birgitt Schüle, Christine Klein, Viji Shridhar, Lewis R. Roberts, David I. Smith. Parkin gene alterations in hepatocellular carcinoma. Genes, Chromosomes and Cancer 2004; 40(2): 85 doi: 10.1002/gcc.20020
|
| 9 |
Krystyna Stec-Michalska, Slawomir Antoszczyk, Grazyna Klupinska, Barbara Nawrot. Loss of <italic>FHIT</italic> expression in gastric mucosa of patients with family histories of gastric cancer and <italic>Helicobacter pylori</italic> infection. World Journal of Gastroenterology 2005; 11(1): 17-21 doi: 10.3748/wjg.v11.i1.17
|
| 10 |
Mark A. Feitelson, Jungmin Lee. Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis. Cancer Letters 2007; 252(2): 157 doi: 10.1016/j.canlet.2006.11.010
|
| 11 |
T. Padma Priya, V. K. Kapoor, Narendra Krishnani, Vinita Agrawal, Suraksha Agarwal. Fragile Histidine Triad (FHIT) Gene and Its Association with p53 Protein Expression in the Progression of Gall Bladder Cancer. Cancer Investigation 2009; 27(7): 764 doi: 10.1080/07357900802711304
|
| 12 |
Sanjay Kakar. Molecular Pathology of Liver Diseases. Molecular Pathology Library 2011; 5: 849 doi: 10.1007/978-1-4419-7107-4_57
|
| 13 |
Yu-Ping Xiao, Dong-Ying Wu, Lei Xu, Yan Xin. Loss of heterozygosity and microsatellite instabilities of fragile histidine triad gene in gastric carcinoma. World Journal of Gastroenterology 2006; 12(23): 3766-3769 doi: 10.3748/wjg.v12.i23.3766
|
| 14 |
Rajesh Kannangai, Fikret Sahin, Onikepe Adegbola, Raheela Ashfaq, Gloria H Su, Michael Torbenson. FHIT mRNA and protein expression in hepatocellular carcinoma. Modern Pathology 2004; 17(6): 653 doi: 10.1038/modpathol.3800102
|
| 15 |
Mari Iida, Colleen H. Anna, Wanda M. Holliday, Jennifer B. Collins, Michael L. Cunningham, Robert C. Sills, Theodora R. Devereux. Unique patterns of gene expression changes in liver after treatment of mice for 2 weeks with different known carcinogens and non-carcinogens. Carcinogenesis 2005; 26(3): 689 doi: 10.1093/carcin/bgi005
|
| 16 |
Sarah E. Gray, Elaine Kay, Mary Leader, Mohamed Mabruk. Analysis of FHIT allelic imbalance/loss of heterozygosity and FHIT expression in cutaneous squamous cell carcinomas. Journal of Cutaneous Pathology 2008; 35(9): 816 doi: 10.1111/j.1600-0560.2007.00913.x
|
| 17 |
Chang Woo Nam, Jung Woo Shin, Neung Hwa Park. Fragile histidine triad gene alterations are not essential for hepatocellular carcinoma development in South Korea. World Journal of Gastroenterology 2008; 14(22): 3526-3533 doi: 10.3748/wjg.14.3526
Abstract(614) |
Core Tip(494) |
Full Article(HTML)(2225)
|
Full Article (PDF)-890K(321)
|
Times Cited (0)
|
Total Visits (4085)
|
Open
|